Plasmid Info:
Plasmid Information
Product Name: pSF-CMV-NH2-V5-EKT-NcoI
Product Code: OG91
Size (bp): 4280 bp
Bacterial Antibiotic Selection: KanR
Origin and Compatibility: pUC high copy derived from pBR322
Bacterial Copy Number: 500-700 per cell
Promoter: Cytomegalovirus (CMV) immediate early promoter
Plasmid Purpose:
This vector adds a V5 epitope tag to the N-terminus of a protein that is encoded within the multiple cloning site. This tag allows the detection and purification of a tagged protein using antibodies raised against the Influenza V5 epitope. The V5 tag coding sequence is GKPIPNPLLGLDST. There is an enterokinase cleavage site (DDDDK) immediately downstream of the V5 tag that can be used to remove the V5 tag from a purified protein. It cleaves after the lysine residue.
Promoter Expression Level:This plasmid contains the mammalian CMV promoter to drive gene expression. We have tested all of our mammalian promoters in a range of cell types and CMV is consistently the strongest in those we have studied. However there are many reports of the CMV promoter demonstrating silencing by methylation in long-term culture. For this reason we stock a range of other promoters that are compatible with this plasmid and are available on request.

Sequence and Map:
Other Info:
Transcription Termination:This plasmid contains three alternative transcription terminators for mammalian bacterial and bacteriophage (T7) expression. This means that only the promoter needs to be changed to alter the expression system you are using. We sell multiple promoters that can be used in each of these systems. The presence of each terminator does not reduce expression in the alternative systems.
Cloning:
Cloning in a Gene:This vector has been designed to allow the addition of a peptide tag to the end of a protein of interest using standard cloning techniques.
Multiple Cloning Site Notes:There is a start codon in the NcoI site can be removed by digestion with KpnI if required. The MCS for gene insertions extends from NotI to XbaI however the tag resides between the NotI and HindIII sites. There are Shine-Dalgarno sequences and KOZAK sequences aligned with the start codon of the peptide tag.
The ClaI to NheI sites have other functions such as adding C-terminal peptide tags second promoters or IRES expression components. The BsgI and BseRI restriction sites cleave within the stop codon in the XbaI site and allow the retrospective fusion of C-terminal peptide tags sequences if the stop codon is placed in this position.
IP Status:
Intellectual Property StatusThis product is part of our SnapFast plasmid range, for more information on the Intellectual property status of this plasmid please click here
ebiomall.com
>
>
>
>
>
>
>
>
>
>
>
>
启动子是RNA聚合酶能够识别并与之结合,从而起始基因转录的一段DNA序列,通常位于基因上游.一个典型的启 动子包括CAAT-box和TATA-box,它们分别依赖DNA的RNA聚合酶的识别和结合位点,一般位于转录起始位点上游几十个碱基处.在核心启动子上 游通常会有一些特殊的DNA序列,即顺式作用元件,转录因子与之结合从而激活或抑制基因的转录.一旦RNA聚合酶定位并结合在启动子上即可 启动基因转录,因此启动子是基因表达调控的重要元件,它与RNA聚合酶及其他蛋白辅助因子等反式作用因子的相互作用是启动子调控基因转录的实质.
根据启动子的转录模式可将其分为3类:组成型启动子、组织或器官特异性启动子和诱导型启动子.
似乎都是鉴定目的基因是否导入受体细胞 没有鉴定是否成功导入质粒的 鉴定目的基因是否导入受体细胞有四个层次 1 直接鉴定受体细胞中是否有目的基因 用DNA分子杂交 2 鉴定目的基因是否转录 分子杂交(mRNA) 3 目的基因是否表达 抗原-抗体 (蛋白质) 4 看受体细胞发育成的个体是否表现出相关性状
各位大神,我现在用PET28α作为表达载体,在连接的时候是不是载体要进行双酶切、胶回收?我双酶切的目的片段和PET28α连接后,导入感受态中没有成功,不知道怎么回事,请教各位。
2、基因表达载体的构建
(1)目的:使目的基因在受体细胞中稳定存在并且可以遗传给下一代并表达和发挥作用.(2)基因表达载体的组成:目的基因+启动子+终止子+标记基因
②启动子在基因的首段,它是RNA聚合酶的结合位点,能控制着转录的开始,故②正确;
③终止子在基因的尾端,它控制着转录的结束,故③正确;
④由于受体细胞有植物、动物以及微生物之分,以及目的基因导入受体细胞的方法不同,因此基因表达载体的构建是不完全相同的,

![]()
暂无品牌分类
